Drugs / GW805858
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00453791 | Feb → Apr 2006 | asthma | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW805858 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00453791 ↗ |
| Route | Inhaled | “GW805858 MDI will be given with dose of 150 micrograms per metered actuation and 120 actuations per inhaler.” NCT00453791 ↗ |